IN THE NEWS
Degussa Goldschmidt, Helix BioMedix Announce Peptide Partnership
2007-09-05 | 09:00
Goldschmidt GmbH and Helix BioMedix, Inc. announced an agreement through which Degussa Goldschmidt Personal Care will become Helix BioMedix’s exclusive marketing partner for its Combikine and Replikine class of anti-aging peptides in addition to other sel
Goldschmidt GmbH, a wholly-owned subsidiary of Degussa GmbH and global manufacturer of raw materials, additives and active ingredients for the cosmetic industry, and Helix BioMedix, Inc., a biopharmaceutical company with an extensive library of diverse bioactive peptides, announced an agreement through which Degussa Goldschmidt Personal Care will become Helix BioMedix’s exclusive marketing partner for its Combikine and Replikine class of anti-aging peptides in addition to other selected peptides targeted at skin care applications.
“We are extremely pleased about our agreement with Helix BioMedix since it will allow us to complement our existing product portfolio of specialty and active ingredients for the cosmetic industry,” said Willy Klipp, senior vice president and general manager of Goldschmidt, Personal Care. “This cooperation is a further important move in growing our customer relationships and guaranteeing the consistent implementation of our overall strategy. We are currently evaluating several peptides and plan that initial products developed as a result of this partnership will be commercially available as of 2008.”
“We are extremely pleased about our agreement with Helix BioMedix since it will allow us to complement our existing product portfolio of specialty and active ingredients for the cosmetic industry,” said Willy Klipp, senior vice president and general manager of Goldschmidt, Personal Care. “This cooperation is a further important move in growing our customer relationships and guaranteeing the consistent implementation of our overall strategy. We are currently evaluating several peptides and plan that initial products developed as a result of this partnership will be commercially available as of 2008.”


































